BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29957370)

  • 1. Effectiveness of watchful waiting versus antidepressants for patients diagnosed of mild to moderate depression in primary care: A 12-month pragmatic clinical trial (INFAP study).
    Iglesias-González M; Aznar-Lou I; Peñarrubia-María MT; Gil-Girbau M; Fernández-Vergel R; Alonso J; Serrano-Blanco A; Rubio-Valera M
    Eur Psychiatry; 2018 Sep; 53():66-73. PubMed ID: 29957370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
    Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
    BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing watchful waiting with antidepressants for the management of subclinical depression symptoms to mild-moderate depression in primary care: a systematic review.
    Iglesias-González M; Aznar-Lou I; Gil-Girbau M; Moreno-Peral P; Peñarrubia-María MT; Rubio-Valera M; Serrano-Blanco A
    Fam Pract; 2017 Nov; 34(6):639-648. PubMed ID: 28985309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
    King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
    Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study).
    Rubio-Valera M; Peñarrubia-María MT; Iglesias-González M; Knapp M; McCrone P; Roig M; Sabes-Figuera R; Luciano JV; Mendive JM; Murrugara-Centurión AG; Alonso J; Serrano-Blanco A
    Eur J Health Econ; 2019 Jul; 20(5):703-713. PubMed ID: 30725226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of patient preference and primary care clinician proclivity for watchful waiting on receipt of depression treatment.
    Johnson MD; Meredith LS; Hickey SC; Wells KB
    Gen Hosp Psychiatry; 2006; 28(5):379-86. PubMed ID: 16950372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for the THREAD (THREshold for AntiDepressants) study: a randomised controlled trial to determine the clinical and cost-effectiveness of antidepressants plus supportive care, versus supportive care alone, for mild to moderate depression in UK general practice.
    Chatwin J; Kendrick T;
    BMC Fam Pract; 2007 Jan; 8():2. PubMed ID: 17204136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness of usual care with or without antidepressant medication for primary care patients with minor or mild-major depression: a randomized equivalence trial.
    Hermens ML; van Hout HP; Terluin B; Adèr HJ; Penninx BW; van Marwijk HW; Bosmans JE; van Dyck R; de Haan M
    BMC Med; 2007 Dec; 5():36. PubMed ID: 18067659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Watchful waiting for subthreshold depression and anxiety in visually impaired older adults.
    van der Aa HP; Krijnen-de Bruin E; van Rens GH; Twisk JW; van Nispen RM
    Qual Life Res; 2015 Dec; 24(12):2885-93. PubMed ID: 26085328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression.
    Simpson S; Corney R; Fitzgerald P; Beecham J
    Health Technol Assess; 2000; 4(36):1-83. PubMed ID: 11134918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a self-rating scale to monitor depression severity in recurrent GP consultations in primary care - does it really make a difference? A randomised controlled study.
    Wikberg C; Westman J; Petersson EL; Larsson ME; André M; Eggertsen R; Thorn J; Ågren H; Björkelund C
    BMC Fam Pract; 2017 Jan; 18(1):6. PubMed ID: 28103816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: A pragmatic cluster randomized controlled trial.
    Pols AD; van Dijk SE; Bosmans JE; Hoekstra T; van Marwijk HWJ; van Tulder MW; Adriaanse MC
    PLoS One; 2017; 12(8):e0181023. PubMed ID: 28763451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year effects and cost-effectiveness of pelvic floor muscle training in mild pelvic organ prolapse: a randomised controlled trial in primary care.
    Panman C; Wiegersma M; Kollen BJ; Berger MY; Lisman-Van Leeuwen Y; Vermeulen KM; Dekker JH
    BJOG; 2017 Feb; 124(3):511-520. PubMed ID: 26996291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of care managers in collaborative care for patients with depression in Swedish primary health care: a pragmatic cluster randomized controlled trial.
    Björkelund C; Svenningsson I; Hange D; Udo C; Petersson EL; Ariai N; Nejati S; Wessman C; Wikberg C; André M; Wallin L; Westman J
    BMC Fam Pract; 2018 Feb; 19(1):28. PubMed ID: 29426288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
    Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
    Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of internet-mediated cognitive behavioural therapy for depression in the primary care setting: results based on a controlled trial.
    Holst A; Björkelund C; Metsini A; Madsen JH; Hange D; Petersson EL; Eriksson MC; Kivi M; Andersson PÅ; Svensson M
    BMJ Open; 2018 Jun; 8(6):e019716. PubMed ID: 29903785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care.
    Sobocki P; Ekman M; Agren H; Krakau I; Runeson B; Mårtensson B; Jönsson B
    Value Health; 2007; 10(2):153-60. PubMed ID: 17391424
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.